H2AJ: H2A.J Histone Member
A variant histone gene involved in chromatin structure and transcriptional regulation
Gene Information Card
| Symbol | H2AJ |
|---|---|
| Full Name | H2A.J histone |
| Gene Type | protein-coding |
| Chromosomal Location | 12p12.1 |
| NCBI Gene ID | 55766 ncbi.nlm.nih.gov/gene/55766 |
| Ensembl ID | ENSG00000111247 |
| UniProt ID | Q9BTM1 |
| OMIM ID | 613399 |
| HGNC ID | 4736 |
| Aliases | H2A.J, H2AFJ |
Description
H2AJ (H2A.J histone) is a protein-coding gene that encodes a member of the histone H2A family. Histones are basic nuclear proteins responsible for nucleosome structure, which packages DNA into chromatin. H2AJ is a replication-independent histone variant that replaces conventional H2A in specific chromatin regions and is implicated in transcriptional regulation, DNA repair, and chromosome stability. It is expressed in various tissues and is associated with certain cancers and developmental disorders.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer (various types) | Altered chromatin remodeling due to H2AJ mutations or dysregulation may affect gene expression and genomic stability. | COSMIC database reports somatic mutations in multiple cancer types. |
| No specific Mendelian disease curated in OMIM | No direct mechanism established | OMIM entry 613399 notes no disease association as of current update. |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | 12.5 | Medium |
| Bone marrow | 8.2 | Low |
| Lymph node | 7.1 | Low |
| Brain | 5.3 | Low |
| Liver | 4.0 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | 15.0 | Embryonic kidney cell line |
| HeLa | 12.3 | Cervical cancer cell line |
| K562 | 9.8 | Leukemia cell line |
| A549 | 7.5 | Lung cancer cell line |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.100G>A (p.Gly34Arg) | Missense | 0.02% in COSMIC | Unknown functional impact; observed in colorectal cancer |
| c.200C>T (p.Thr67Met) | Missense | 0.01% in COSMIC | Unknown functional impact; observed in lung cancer |
Mutation functional classification
Loss of Function (LOF)
No confirmed loss-of-function mutations reported in curated databases.
Gain of Function (GOF)
No confirmed gain-of-function mutations reported in curated databases.
Dominant Negative (DN)
No confirmed dominant-negative mutations reported in curated databases.
View complete mutation data:
Gene Ontology (GO)
| • nucleosome (GO:0000786) | • DNA binding (GO:0003677) |
| • nucleus (GO:0005634) | • nucleosome assembly (GO:0006334) |
| • protein heterodimerization activity (GO:0046982) |
Pathways
• Chromatin organization (Reactome: R-HSA-4839726)
• Packaging of telomere ends (Reactome: R-HSA-171306)
Protein Summary
H2AJ is a histone H2A variant that replaces conventional H2A in nucleosomes. It contains a conserved histone fold domain and a C-terminal tail. Unlike replication-dependent histones, H2AJ is expressed throughout the cell cycle and is incorporated into chromatin independently of DNA replication. It plays roles in chromatin structure modulation, transcriptional regulation, and DNA damage response. The protein is ubiquitously expressed at low levels, with highest abundance in testis and bone marrow.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| H2AJ Knockout HeLa Cell Line | EDJ-KQ43436 | Human | 55766 | Details Get a Quote |
| H2AJ Knockout HCT 116 Cell Line | EDJ-KQ43435 | Human | 55766 | Details Get a Quote |
| H2AJ Knockout A-549 Cell Line | EDJ-KQ43434 | Human | 55766 | Details Get a Quote |
| H2AJ Knockout HEK293 Cell Line | EDJ-KQ13707 | Human | 55766 | Details Get a Quote |